Ongoing phase III induction/maintenance clinical trials in PTCL
| Trials . | NCT # . | Title . | Setting . |
|---|---|---|---|
| ECHELON-2 | 01777152 | A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas | Induction |
| Ro-CHOP | 01796002 | Phase 3 Multi-center Randomized Study to Compare Efficacy and Safety of Romidepsin CHOP (Ro-CHOP) Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma | Induction |
| A-CHOP-14 | 00725231 | Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP | Induction |
| Pralatrexate | 01420679 | Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients | Maintenance |
| Trials . | NCT # . | Title . | Setting . |
|---|---|---|---|
| ECHELON-2 | 01777152 | A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas | Induction |
| Ro-CHOP | 01796002 | Phase 3 Multi-center Randomized Study to Compare Efficacy and Safety of Romidepsin CHOP (Ro-CHOP) Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma | Induction |
| A-CHOP-14 | 00725231 | Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP | Induction |
| Pralatrexate | 01420679 | Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients | Maintenance |
NCT, national clinical trial.